JLABS , 3210 Merryfield Row , San Diego , California
June 14, 2018 from 12:30 PM to 14:00 PM (PDT)
$10 - $35
For more than 40 years, Johnson & Johnson Innovation - JJDC, Inc. has made investments in hundreds of innovative companies across the pharmaceutical, medical device and consumer healthcare sectors. By allowing innovators to leverage Johnson & Johnson’s many resources, JJDC helps turn transformative ideas into real solutions for today’s patients. From seed-level start-ups to Series B and beyond, JJDC is seeking innovations with the potential to make an impact in healthcare among lives of people around the globe in the following sectors:
- Baby care
- Oral care
- Compromised Skin
- Feminine Personal Care
- Surgerical oncology
- Infectious Diseases & Vaccines
- Cardiovascular & Metabolism
- Pulmonary Hypertension
Vijay Murthy, Ph.D, Principal of Venture Investments, will be in attendance to provide an overview of JJDC’s unique investment approach in emerging life science and biotechnology healthcare companies. After the presentation and networking lunch, Vijay will meet 1-on-1 with pre-selected companies. To be considered for a 1-on-1 meeting complete the information required here.
Vijay Murthy, Ph.D | Principal of Venture Investments, Johnson & Johnson Innovation, JJDC Inc. read bio»
10:30 AM | Registration Opens and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking Lunch
12:30-5:00 PM | One-on-one Meetings* (30 - minute meetings)
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on May 18th, 2018.
Presentation & Lunch
FREE | General Public
FREE | Onsite
Includes presentation, Q&A, and lunch. All attendees must register, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on June 13 (or sold out).
FREE | Application
FREE | Accepted Companies
*Companies must have applied for a one-on-one meeting ahead of time and been approved.
JLABS in San Diego
3210 Merryfield Row
San Diego, CA 92121
Participating Representatives' Biographies:
Vijay Murthy, Ph.D | Principal Venture of Investments, Johnson & Johnson Innovation, JJDC Inc.
Vijay is a Principal of Venture Investments at Johnson & Johnson Innovation, JJDC. Inc. (JJDC) and is based in the Johnson & Johnson Innovation Center in California. Vijay focuses on venture investments in biotechnology, pharmaceuticals, and diagnostics. Prior to joining JJDC, Vijay was a Director of Ventures & Early-Stage Collaborations at AbbVie, where he focused on venture investments and preclinical business development transactions. Prior to AbbVie, Vijay was co-founder and CEO of an early-stage peptide manufacturing company, and an independent consultant to several top-tier life sciences venture capital firms and biopharmaceutical companies. Previously, Vijay led business development at Enlight Biosciences, a seed-stage venture creation firm founded by PureTech Health and partnered with 7 major biopharmaceutical companies. He started his business career as a strategy consultant at the Boston Consulting Group (BCG). Vijay earned an MA and a PhD in biophysical chemistry from Harvard University, and a BS in chemistry with highest honors and highest distinction from the University of North Carolina at Chapel Hill.
Connect with Vijay:
About the Meet With... Series:
The purpose of the Meet with series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, OrbiMed, Osage University Partners, Spectrum 28, Quark Venture, and AbbVie Ventures.